Case Report on Full Term Normal Delivery

2020 ◽  
Vol 20 (4) ◽  
2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Alberto Berardi ◽  
Cecilia Rossi ◽  
Valentina Fiorini ◽  
Cristina Rivi ◽  
Federica Vagnarelli ◽  
...  

PEDIATRICS ◽  
1991 ◽  
Vol 88 (2) ◽  
pp. 334-337
Author(s):  
GARY L. FRANCIS ◽  
JAMES J. JELINEK ◽  
KATHLEEN MCHALE ◽  
MEGAN ADAMSON ◽  
SONDRA W. LEVIN

The Weismann-Netter syndrome is a rare, heritable skeletal dysplasia which often presents as asymptomatic bowing of the lower legs or short stature.1 Although more than 40 cases have been described, there is mention of only 8 cases in patients who were younger than 16 years of age.1-9 In retrospect, most of the affected adults reported symptoms during childhood. We recently had the opportunity to evaluate a 4-year-old boy, whom we believe to have the Weismann-Netter syndrome. This case served to heighten our awareness of this condition, which should be recognizable in the pediatric age range. CASE REPORT The proband (Fig 1), a four-year-old Arabic boy, was the product of a full-term, uncomplicated pregnancy.


PEDIATRICS ◽  
1973 ◽  
Vol 51 (2) ◽  
pp. 311-312
Author(s):  
L. Michael Fiengold

The case reported by Drs. Keidel and Feingold of Wilson Mikity Disease in a full-term infant indeed had meconium aspiration as a component. However, the baby went on to have oxygen dependency for at least a month following birth. This of course differs entirely from the syndrome of meconium aspiration. Moreover, the case was reviewed by Dr. Arnold Rudolph and Dr. Victor Mikity who read the x-rays personally. There is no doubt that the case report is valid and can clearly be differentiated from the course of the two infants that Dr. Cohen reported.


PEDIATRICS ◽  
1971 ◽  
Vol 48 (3) ◽  
pp. 345-348
Author(s):  
George H. Fetterman

No pediatrician with responsibility for the care of newborn infants, premature or full term, can fail to be interested in the syndrome of neonatal necrotizing enterocolitis. The recent outpouring of reports concerning the disease attests not only to the growing recognition of the problem but also the immediacy of the challenge which it presents. The challenge is twofold, demanding clinical diagnosis of the disease at an early stage as well as study directed toward the elucidation of its etiology and pathogenesis. The most quoted articles from the European literature are Genersich's1 original case report in 1891, the series of 62 cases described by Willi2 in 1944, and the series reported by Rossier, et al.3 in 1959.


PEDIATRICS ◽  
1977 ◽  
Vol 59 (6) ◽  
pp. 1057-1058
Author(s):  
Eduardo Mazzi ◽  
John J. White ◽  
Hiroshi Nishida ◽  
Herman M. Risemberg

Hemothorax that produces acute respiratory distress in a newborn occurs rarely; only ten cases have been reported.1-9 We report another case (associated with hypoprothrombinemia and anemia) in a full-term infant. Thoracentesis successfully relieved the respiratory distress, and transfusion and parenteral vitamin K therapy reversed the bleeding diathesis. CASE REPORT A girl, weighing 3,070 gm, was born to a 30-year-old woman, after spontaneous labor and uncomplicated delivery. The Apgar score was 7 at one and five minutes. The infant was brought to the nursery at 10 minutes of age, where she was found to be a cyanotic black girl with grunting respirations and intercostal retractions.


2018 ◽  
Vol 08 (05) ◽  
Author(s):  
Elfakir S ◽  
Zouita B ◽  
Basraoui D ◽  
Hicham Jalal

2019 ◽  
pp. 1-11 ◽  
Author(s):  
Irappa Madabhavi ◽  
Malay Sarkar ◽  
Mitul Modi ◽  
Nagaveni Kadakol

PURPOSE The aim of the current work was to report the effect of imatinib on pregnancy in patients with chronic myeloid leukemia (CML). METHODS Data were collected between January 1998 and December 2014. One hundred four patients met inclusion criteria, and we report the results of 104 pregnancies—conceived by the participant or partner—while being on imatinib therapy for CML. RESULTS Fifty-eight patients were male and 46 were female. Eighty-three patients, 20 patients, and one patient were had CML in the chronic phase, accelerated phase, or blast phase, respectively. Of 46 female patients, 21 underwent abortion (spontaneous, n = 36.9; elective termination, n = 8.6%). In the case of full-term pregnancy in the female partners of male patients with CML, all outcomes were uneventful. Of 46 female patients, 25 had full-term pregnancy outcomes. During the pre–imatinib era (total n = 6), patients were treated with hydroxyurea, interferon-alpha, and therapeutic leukapheresis. A total 10 of 19 pregnant patients continued on imatinib until their delivery and experienced the following outcomes: normal full-term deliveries (n = 7), preterm delivery (n = 1), omphalocele (n = 1), and craniosynostosis (n = 1). Of those who discontinued imatinib after counseling (n = 9), eight patients had full-term normal delivery, of which two patients required leukapheresis and one patient expired. All patients who continued on imatinib while pregnant were in complete cytogenetic response and major molecular response (MMR) before pregnancy, during pregnancy, and postpregnancy. Of nine patients who discontinued imatinib, two lost MMR during the third trimester and all of these patients were in complete cytogenetic response and MMR before pregnancy. CONCLUSION It is clear that there is no standard of care for the best treatment of CML in the case of pregnancy. Interferon and/or leukapheresis will be included as treatment options. Patients can have normal pregnancies even with the administration of imatinib at the risk of congenital anomalies, intervention for which can be done after birth.


2020 ◽  
Vol 11 ◽  
Author(s):  
Martin Jouza ◽  
Tomas Jimramovsky ◽  
Eva Sloukova ◽  
Jakub Pecl ◽  
Anna Seehofnerova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document